US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 48.050
  • -0.450-0.93%
Close Jul 26 16:00 ET
  • 48.250
  • +0.200+0.42%
Post 20:02 ET
2.73BMarket Cap-7614P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agios Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

9.31M

+38.67%
EPS(YoY)

-1.60

-6.10%
Analyst Rating

Strong Buy

Jul 28, 2024

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.746M--
Aug 1, 20242024/Q2-- / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--
Nov 2, 20232023/Q37.399M / 7.526M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.746M--
Aug 1, 20242024/Q2-- / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--
Nov 2, 20232023/Q37.399M / 7.526M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

  • Agios Pharmaceuticals | 10-Q: Quarterly report

    May 2 09:23 ET

  • Agios Pharmaceuticals | 10-K: Annual report

    Feb 15 10:37 ET

  • Agios Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 09:20 ET

  • Agios Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 09:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 28, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg